Clinical Trial Update: Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

A Phase 1 bio-equivalence study in acne vulgaris completed, assessing clinical endpoints between two formulations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED